Welcome Message from Our CEO
Welcome to Watson.com, your portal for understanding our business, and the vision, legacy and quality supporting the impressive growth of Watson Pharmaceuticals, Inc.
Watson is an industry leader with a track record of breaking new ground. We have
achieved leadership as the 5th largest pharmaceutical company and the 3rd largest
supplier of generic pharmaceutical products in the U.S., based on total prescriptions
dispensed1. For more than two decades, our flexible
business model
- balanced between the Brand and Generic businesses and complemented by a Distribution
arm – along with our opportunistic approach to handling changes in
our industry has enabled us to achieve growth in all types of market conditions
and industry cycles. We think our ability to anticipate and manage change while
remaining relevant to our customers are the attributes that makes
us a different kind of specialty pharmaceutical company.
Through our people, one of our greatest assets, we are able to maintain a strong Brand pipeline with a far-reaching urology portfolio and a prolific Generic pipeline with more than 70 ANDAs currently filed. Our offshore activities offer us great flexibility and cost efficiencies. This strong and capable mix coupled with a commitment to research and development and a comprehensive array of drug delivery technology allows us to bring products to market quickly and cost effectively.
Over the years, we have also remained dedicated to "Doing The Right Thing®." We have conducted our business with integrity, never losing sight of the people who use our products. We plan to continue "Doing The Right Thing®" — by being opportunistic within the business, being relevant for our customers and for the patients they serve, and being profitable for our shareholders who make our continued growth possible.
Whether you have come to this site as an investor, future employee, medical professional, consumer, family member or friend, we invite you to become familiar with our business and share in our purpose of enriching human lives.
Paul Bisaro
President and Chief Executive Officer
1Source: IMS Health, March 2007
